Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1Breast 1

Conditions

Breast Neoplasms 11Breast Carcinoma In Situ 2Weight Loss 1Paget's Disease, Mammary 1Neoplasms 1Fatigue 1Cognitive Dysfunction 1Carcinoma, Intraductal, Noninfiltrating 1Arthralgia 1

Interventions

Paclitaxel 26pembrolizumab 24Docetaxel 20Capecitabine 19Fulvestrant 17Trastuzumab 16Anastrozole 15Cyclophosphamide 14Lapatinib 13Letrozole 11Carboplatin 11Radiotherapy 10Doxorubicin 10palbociclib 9Therapeutics 9Nivolumab 9Exercise 9Gemcitabine 8Cisplatin 8Blood Specimen Collection 8Tamoxifen 7Bevacizumab 7liposomal doxorubicin 6exemestane 6abemaciclib 6Vinorelbine 6Standard of Care 6Fluorouracil 6atezolizumab 5Surveys and Questionnaires 5

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Neoplasms × Docosahexaenoic Acids × Breast × Clear all
NCT02352779 2017-08-08

Omega-3 Fatty Acid in Reducing Cancer-Related Fatigue in Breast Cancer Survivors

University of Rochester

Phase NA Completed
108 enrolled 17 charts
Breast

Breast Neoplasms, Fatigue, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡